Lecithin promotes adipocyte differentiation and hepatic lipid accumulation

International Journal of Molecular Medicine

Volumn 23, Issue 4, 2009, Pages 449-454

  Zhang, Yuebo ^a   Huang, Cheng ^a   Sheng, Xiaoyan ^a   Gong, Zhenwei ^a   Zang, Ying Qin ^a  

^a Chinese Academy of Sciences   (China)

Author keywords

Adipocyte differentiation; Hepatic lipid deposit; Lecithin

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; FATTY ACID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LEVEL; CELL PROLIFERATION; CELL STRAIN 3T3; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; LIPID STORAGE; LIPOGENESIS; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SYNERGISM; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION; GLUCOSE; HUMANS; INSULIN; LECITHINS; LIVER NEOPLASMS; MICE; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 67649443808     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000150     Document Type: Article

References (24)

1. Fiume Z: Final report on the safety assessment of lecithin and hydrogenated lecithin. Int J Toxicol 20 (suppl 1): 21-45, 2001.
2. Goyal J, Wang K, Liu M and Subbaiah PV: Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation. J Biol Chem 272: 16231-16239, 1997.
3. Vohl MC, Neville TA, Kumarathasan R, Braschi S and Sparks DL: A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation. Biochemistry 38: 5976-5981, 1999.
4. Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K, Gornbein J, Ament ME and Eckhert CD: Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 102: 1363-1370, 1992.
5. Ulkowski M, Musialik M and Litwinienko G: Use of differential scanning calorimetry to study lipid oxidation. 1. Oxidative stability of lecithin and linolenic acid. J Agric Food Chem 53: 9073-9077, 2005.
6. Wood JL and Allison RG: Effects of consumption of choline and lecithin on neurological and cardiovascular systems. Fed Proc 41: 3015-3021, 1982.
7. Kumar R and Katare OP: Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review. AAPS PharmSciTech 6: E298-E310, 2005.
8. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM and Lehmann JM: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94: 4318-4323, 1997.
9. Rosen ED, Walkey CJ, Puigserver P and Spiegelman BM: Transcriptional regulation of adipogenesis. Genes Dev 14: 1293-1307, 2001.
10. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM and Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270: 12953-12956, 1995.
11. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM and Evans RM: 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812, 1995.
12. Tontonoz P, Hu E and Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79: 1147-1156, 1994.
13. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A and Evans RM: PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585-595, 1999.
14. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM and Mortensen RM: PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4: 611-617, 1999.
15. Bjorntorp P, Karlsson M, Pertoft H, Pettersson P, Sjostrom L and Smith U: Isolation and characterization of cells from rat adipose tissue developing into adipocytes. J Lipid Res 19: 316-324, 1978.
16. Huang C, Zhang Y, Gong Z, Sheng X, Li Z, Zhang W and Qin Y: Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem Biophys Res Commun 348: 571-578, 2006.
17. Tanishita T, Shimizu Y, Minokoshi Y and Shimazu T: The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin. J Biochem (Tokyo) 122: 90-95, 1997.
18. Lakshman MR: Some novel insights into the pathogenesis of alcoholic steatosis. Alcohol 34: 45-48, 2004.
19. Tang QQ, Otto TC and Lane MD: Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci USA 100: 44-49, 2003.
20. Tzameli I, Fang H, Ollero M, Shi H, Hamm JK, Kievit P, Hollenberg AN and Flier JS: Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem 279: 36093-36102, 2004.
21. Escriba PV: Membrane-lipid therapy: a new approach in molecular medicine. Trends Mol Med 12: 34-43, 2006.
22. Schadinger SE, Bucher NL, Schreiber BM and Farmer SR: PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab 288: E1195-E1205, 2005.
23. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ and Reddy JK: Adipocytespecific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 278: 498-505, 2003.
24. Ness-Abramof R and Apovian CM: Drug-induced weight gain. Drugs Today 41: 547-555, 2005.